Continuous manufacturing of orally dissolving webs containing a poorly soluble drug via electrospinning

Domokos, András and Balogh, Attila and Dénes, Dániel and Nyerges, Gyula and Ződi, Levente and Farkas, Balázs and Marosi, György and Nagy, Zsombor Kristóf (2018) Continuous manufacturing of orally dissolving webs containing a poorly soluble drug via electrospinning. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 130. pp. 91-99. ISSN 0928-0987

Text Continuous_orally_dissolving_webs_2019.pdf Restricted to Registered users only Download (2MB)

Abstract

An orally dissolving web (ODW) formulation of poorly soluble carvedilol (CAR) was developed and manufactured continuously using electrospinning (ES) as a key technology. Phase solubility tests revealed that hydroxypropyl-β-cyclodextrin (HPβCD) solubilizer alone cannot ensure sufficient solubility (6.25 mg CAR in 20 mL) in the oral cavity even if citric acid was present to ionize the basic drug. In turn, electrospun amorphous nanofibers of polyvinylpyrrolidone K30 (PVPK30) and CAR exhibited notable supersaturation of the drug in the presence of citric acid. Differential scanning calorimetry (DSC) and X-ray powder diffraction (XRPD) confirmed the amorphous state of CAR. The final ODW was prepared by layering the nanofibers onto pullulan, a well-soluble polysaccharide film carrying citric acid. The double-layered formulation showed ultrafast disintegration and dissolution modeling the oral cavity meeting regulatory requirements (<30 s). The continuous production was accomplished using our recently developed continuous model system by controlled deposition of the nanofibers onto the carrier film strained to a wheel collector and followed by cutting into final dosage units. Performance tests of the continuous system revealed satisfactory content uniformity over time (average acceptance value = 9.45), while residual solvent content measurements showed trace amounts of ethanol (EtOH) after production and acceptable dimethyl-formamide (DMF) content with secondary drying at room temperature. The presented work demonstrates how ES can be part of a continuous manufacturing system as an advanced drying tool during the formulation of challenging drugs.

Actions (login required)

Edit Item